Elizabeth R. Gerstner

Neurology

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 146 publications

TRACED: In vivo imaging of extracellular intrinsic diffusivity, tortuosity, cell size distribution and cell density in human glioma patients.

TRACED: In vivo imaging of extracellular intrinsic diffusivity, tortuosity, cell size distribution and cell density in human glioma patients.

Journal: ArXiv

Published: May 18, 2026

Weak supervision of H&E slides reveals systems-level biology and functional states that govern therapeutic resistance.

Weak supervision of H&E slides reveals systems-level biology and functional states that govern therapeutic resistance.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

A deep learning algorithm for fully automated volumetric measurement of meningioma burden.

A deep learning algorithm for fully automated volumetric measurement of meningioma burden.

Journal: Neuro-oncology advances

Published: February 11, 2026

Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 10, 2026

Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy.

Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy.

Journal: Neuro-oncology

Published: October 30, 2025

A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomas.

A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomas.

Journal: Neuro-oncology practice

Published: October 13, 2025

ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings.

ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings.

Journal: bioRxiv : the preprint server for biology

Published: September 05, 2025

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Journal: Neuro-oncology advances

Published: August 04, 2025

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Journal: Neuro-oncology

Published: August 04, 2025

Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.

Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.

Journal: Neuro-oncology

Published: June 28, 2025

Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma.

Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma.

Journal: Neuro-oncology advances

Published: April 08, 2025

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Journal: Nature medicine

Published: February 10, 2025

Showing 1-12 of 146

Last Updated: 09/26/2026